GenMark Diagnostics, Inc. (NASDAQ:GNMK) rose Monday, as Roche Holding AG announced plans to acquire GenMark Diagnostics for $24.05 per share in cash, or about $1.8...
Rubius Therapeutics, Inc. (NASDAQ:RUBY) rose Monday, on trial results from ongoing Phase 1/2 trial of RTX-240 in advanced solid tumors at the American Association of...
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Vale (VALE) downgraded to Underperform from Outperform at Exane...